Adriana Lima Sparks New Health Speculation and Online Backlash in New York
Supermodel Adriana Lima faced a new wave of online criticism and Ozempic speculation during her recent New York appearance, while supporters defended her against relentless body shaming.

Adriana Lima is once again facing a wave of harsh online criticism regarding her appearance. The 45-year-old supermodel was recently spotted in New York City heading to the Today Show, sparking fresh speculation about potential weight-loss drug use.
Over the past few years, Lima has frequently dealt with public scrutiny over her changing looks. However, recent footage has intensified the debate, with many social media users expressing concern over her noticeably slimmer frame and sharp facial features.
Social Media Backlash and Body Image Debates
Critics online did not hold back after the New York appearance, questioning her current lifestyle and physical condition.
She is losing too much muscle and needs to concentrate on staying healthy, not just being thin. Her legs look smaller than her arms,
commented several users, directly pointing to suspected Ozempic use. Paris Fashion Week appearances earlier this season also drew similar remarks, focusing on her prominent jawline and slender physique.
At the same time, numerous defenders stepped in, arguing that public pressure and relentless body shaming are precisely what drive celebrities toward extreme measures.
Defending Her Choices Ahead of the Runway
Supporters noted the double standard women face in the fashion industry, where criticism follows them whether they gain weight or lose it.
-
Public scrutiny has targeted Lima during both heavier and leaner periods of her career.
-
Past facial criticism was previously addressed by Lima herself, who blamed the changes on exhaustion from raising multiple children.
Despite the ongoing online noise, Lima continues her iconic career. She is set to return to the Victoria's Secret runway in Los Angeles, marking her first appearance for the brand in over a decade.




